Results from studies of anti-vascular endothelial growth factor therapy for neovascular age-related macular degeneration can be interpreted in a variety of ways, depending on the baseline bias of the individual.
Welcome to ModernMedicine
There are a variety of new diagnostic tests for dry eye and a number of reasons to incorporate these technologies into practice.
Carl Zeiss Meditec introduces new optical coherence tomography platforms that span the full spectrum of multi-modality imaging for glaucoma and retinal disease.
Quantel Medical has received FDA 510(k) market clearance of its ophthalmic laser system (SupraScan 577 Laser) for treating a wide range of retinal diseases.
Results of a retrospective, observational, multicenter study including 140 eyes demonstrate the safety and efficacy of phakic IOL explantation surgery.
A new wavefront-guided LASIK procedure provides superior cylinder correction, better uncorrected visual acuity outcomes, and slightly higher patient satisfaction.
Quantel Medical and Iridex have signed a global patent licensing agreement that gives Quantel access to Iridex's MicroPulse technology.
The Ophthalmology Innovation Summit provides a forum for the leaders of ophthalmology to look at all aspects of the innovation process to create additional innovation and to circumvent issues that hinder that innovation.
Preliminary results of a preclinical study investigating the effect of peripheral collagen crosslinking on the limbal stem cells provide some reassurance about the safety of the technique.
Heidelberg Engineering has received FDA clearance for its MultiColor scanning laser imaging as a new dimension in multi-modality fundus imaging with the Spectralis product family.